The carrying value of goodwill was $6.3 million as of March 2, 2019 and June 2, 2018. The goodwill balance in its entirety relates to our IMES reporting unit, which is included in our Healthcare segment.

Goodwill is initially recorded based on the premium paid for acquisitions and is subsequently tested for impairment, using the first day of our fourth quarter as the measurement date. We test goodwill for impairment annually and whenever events or circumstances indicate an impairment may have occurred, such as a significant adverse change in the business climate, an adverse action or assessment by a regulator, unanticipated competition, loss of key personnel or a decision to sell or dispose of a reporting unit.

During the first nine months of fiscal 2019, no events or circumstances were identified that would indicate impairment may have occurred. Although the Company has not identified any triggering events in fiscal 2019 that would require a more frequent test for impairment, the IMES reporting unit is experiencing lower than forecasted results through the first nine months of fiscal 2019 due to slower than anticipated sales of its ALTA750^TM tubes and costs associated with its regional expansion. The Company is currently in the process of analyzing internal strategic initiatives to improve operating performance, and forecasting for fiscal 2020 and future years as part of its annual impairment assessment, which is performed as of the first day of our fourth quarter and will be completed in the fourth quarter. As of the date of this filing, the Company has not yet completed its assessment.

Although we believe our projected future operating results and cash flows and related estimates regarding fair values were based on reasonable assumptions, historically, projected operating results and cash flows have not always been achieved. Changes in any of the significant assumptions used, including if the Company does not successfully achieve its operating plan, which is largely dependent on sales from new product offerings, can materially affect the expected cash flows, and such impacts could result in a material non-cash impairment charge of goodwill and other long lived assets.

Potential events or changes in circumstances that could reasonably be expected to negatively affect key assumptions are deterioration in general market conditions or the environment in which the reporting unit or entity operates, an increased competitive environment in which the reporting unit or entity operates or other relevant entity-specific events such as market acceptance of our new CT tubes and other new product offerings, approvals to sell in foreign markets and changes in management or key personnel.

Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with our acquisitions. Intangible assets subject to amortization were as follows (in thousands):

	March 2, 2019		June 2, 2018
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships⁽¹⁾		3,406		3,408
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,472	$	4,474
Accumulated Amortization:
Trade Name	$	657	$	651
Customer Relationships		757		617
Non-compete Agreements		132		115
Technology		97		77
Total Accumulated Amortization	$	1,643	$	1,460

Net Intangibles	$	2,829	$	3,014

(1)	Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands):

Fiscal Year	Amortization Expense
Remaining 2019	$	61
2020		257
2021		245
2022		252
2023		246
Thereafter		1,768
Total amortization expense	$	2,829

The weighted average number of years of amortization expense remaining is 14.7 years.